INO
Inovio Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.66
-0.02 ▼ -1.19%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$1.68
+0.02 ▲ +1.20%
| Index | - | P/E | - | EPS (ttm) | -1.93 | Insider Own | 0.42% | Shs Outstand | 0.07B | Perf Week | -4.6% |
| Market Cap | 0.11B | Forward P/E | - | EPS next Y | 56.27% | Insider Trans | - | Shs Float | 0.07B | Perf Month | 3.11% |
| Enterprise Value | 0.07B | PEG | - | EPS next Q | -0.35 | Inst Own | 48.08% | Short Float | 16.02% | Perf Quarter | -23.5% |
| Income | -0.08B | P/S | 1638.43 | EPS this Y | 33.04% | Inst Trans | 22.18% | Short Ratio | 7.83 | Perf Half Y | -37.36% |
| Sales | 0.00B | P/B | 4.75 | EPS next 5Y | - | ROA | -89.14% | Short Interest | 10.96M | Perf YTD | -4.6% |
| Book/sh | 0.35 | P/C | 1.96 | EPS past 3/5Y | 49.51% 32.44% | ROE | -183.47% | 52W High | -44.27% ($2.98) | Perf Year | -13.99% |
| Cash/sh | 0.85 | P/FCF | - | Sales past 3/5Y | -81.47% -61.18% | ROIC | -277.23% | 52W Low | 27.69% ($1.30) | Perf 3Y | -88.47% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 42.36% | Gross Margin | -4474.06% | Volatility(W/M) | 4.41% 5.34% | Perf 5Y | -98.68% |
| Dividend TTM | - | EV/Sales | 936.43 | Sales Y/Y TTM | -69.99% | Oper. Margin | -132871.32% | ATR (14) | 0.1 | Perf 10Y | -97.99% |
| Dividend Ex-Date | - | Quick Ratio | 1.4 | EPS Q/Q | 109.14% | Profit Margin | -130000% | RSI (14) | 45.15 | Recom | 1.8 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.4 | Sales Q/Q | -100% | SMA20 | -3.96% ($1.73) | Beta | 1.75 | Target Price | $6.76 |
| Payout | - | Debt/Eq | 0.39 | Earnings | 3000000 | SMA50 | 0.41% ($1.65) | Rel Volume | 0.66 | Prev Close | $1.68 |
| Employees | 112 | LT Debt/Eq | 0.27 | EPS/Sales Surpr. | 116.76% - | SMA200 | -15.4% ($1.96) | Avg Volume(3M) | 1.40M | Price | $1.66 |
| IPO | 1998/12/8 | Option/Short | Yes/Yes | Trades | 2498 | Volume | 924,613 | Change | -1.19% |
뉴스 로딩 중...